Veeva Systems today announced that Bristol Myers Squibb has implemented Veeva Vault CTMS (Clinical Trial Management System) globally to drive end-to-end trial management. The new CTMS replaced a ...
Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management. The new CTMS replaced a heritage Celgene CTMS and a heritage Bristol ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BARCELONA, Spain, April 21, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management.
PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute faster, ...
Veeva Systems VEEV announced that more than 150 global enterprises and fast-growing companies are accelerating clinical trial operations with the adoption of Veeva Vault CTMS. With the latest ...
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed Modernization streamlines trial management to speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results